Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various… Read more
Prestige Consumer Healthcare Inc (PBV) - Total Liabilities
Latest total liabilities as of September 2025: €1.62 Billion EUR
Based on the latest financial reports, Prestige Consumer Healthcare Inc (PBV) has total liabilities worth €1.62 Billion EUR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Prestige Consumer Healthcare Inc - Total Liabilities Trend (2014–2025)
This chart illustrates how Prestige Consumer Healthcare Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Prestige Consumer Healthcare Inc Competitors by Total Liabilities
The table below lists competitors of Prestige Consumer Healthcare Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Silicon Motion Technology Corporation
F:S9M
|
Germany | €303.22 Million |
|
Tav Havalimanlari Holding AS
PINK:TAVHY
|
USA | $3.55 Billion |
|
Sulzer Ltd
PINK:SULZF
|
USA | $3.36 Billion |
|
Ningbo Sanxing Medical Electric Co Ltd
SHG:601567
|
China | CN¥11.49 Billion |
|
L&T Finance Limited
NSE:LTF
|
India | ₹1.01 Trillion |
|
Alupar Investimento SA
SA:ALUP11
|
Brazil | R$19.12 Billion |
|
Kokuyo Co., Ltd.
PINK:KUKYF
|
USA | $85.57 Billion |
|
Mineral Res
PINK:MALRY
|
USA | $7.71 Billion |
Liability Composition Analysis (2014–2025)
This chart breaks down Prestige Consumer Healthcare Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.89 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Prestige Consumer Healthcare Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Prestige Consumer Healthcare Inc (2014–2025)
The table below shows the annual total liabilities of Prestige Consumer Healthcare Inc from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | €1.57 Billion | -5.77% |
| 2024-03-31 | €1.66 Billion | -12.76% |
| 2023-03-31 | €1.91 Billion | -8.91% |
| 2022-03-31 | €2.09 Billion | +1.07% |
| 2021-03-31 | €2.07 Billion | -11.61% |
| 2020-03-31 | €2.34 Billion | -0.10% |
| 2019-03-31 | €2.35 Billion | -9.17% |
| 2018-03-31 | €2.58 Billion | -16.41% |
| 2017-03-31 | €3.09 Billion | +40.12% |
| 2016-03-31 | €2.20 Billion | +9.44% |
| 2015-03-31 | €2.01 Billion | +63.46% |
| 2014-03-31 | €1.23 Billion | -- |